Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	174.86	183.58	107.95	122.72	122.47	114.04
Short-Term Investments	177.24	60.05	98.42	67.89	59.73	209.44
Cash & Short-Term Investments	352.1	243.63	206.37	190.61	182.2	323.48
Cash Growth	57.34%	18.05%	8.27%	4.61%	-43.68%	38.61%
Receivables	51.74	41.72	21.27	20.32	3.99	-
Inventory	41.4	26.36	31.12	21.6	3.68	-
Prepaid Expenses	30.29	20.08	17.54	10.54	6.59	9.56
Restricted Cash	-	-	-	-	-	0.21
Total Current Assets	475.53	331.8	276.3	243.06	196.45	333.25
Property, Plant & Equipment	11.73	11.04	12.67	7.04	8.38	10.62
Other Intangible Assets	15.5	16.25	17.25	18.25	19.25	-
Long-Term Deferred Tax Assets	201.29	211.15	219.28	185.5	-	0.01
Other Long-Term Assets	8.29	10.32	0.83	5.82	8.72	5.59
Total Assets	712.33	580.55	526.32	459.67	232.8	349.46
Accounts Payable	6.15	2.04	8.25	7.9	1.87	0.5
Accrued Expenses	94.22	80.51	44.67	30.11	38.03	29.2
Current Portion of Leases	2.7	1.99	2.25	3.3	3.38	2.11
Current Unearned Revenue	-	-	0.31	-	-	-
Other Current Liabilities	20.52	16.08	8.19	5.75	1.54	0.04
Total Current Liabilities	123.59	100.62	63.67	47.07	44.82	31.85
Long-Term Leases	7.02	7.86	10.01	2.62	2.67	4.88
Long-Term Unearned Revenue	31.81	31.81	11.95	12	-	-
Other Long-Term Liabilities	14.53	1.82	1.86	1.84	0.27	0.81
Total Liabilities	176.95	142.12	87.48	63.52	47.76	37.53
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	1,012	959.72	916.76	888.12	860.48	829.42
Retained Earnings	-476.34	-521.14	-477.95	-492.03	-675.4	-517.47
Comprehensive Income & Other	-0.16	-0.16	0.01	0.04	-0.07	-0.03
Total Common Equity	535.38	438.44	438.84	396.15	185.04	311.94
Shareholders' Equity	535.38	438.44	438.84	396.15	185.04	311.94
Total Liabilities & Equity	712.33	580.55	526.32	459.67	232.8	349.46
Total Debt	9.72	9.86	12.26	5.92	6.05	6.99
Net Cash (Debt)	342.38	233.77	194.11	184.69	176.15	316.5
Net Cash Growth	60.60%	20.43%	5.10%	4.85%	-44.34%	37.17%
Net Cash Per Share	4.47	3.27	2.70	2.62	2.57	5.12
Filing Date Shares Outstanding	75.8	72.64	70.62	69.75	69.1	68.23
Total Common Shares Outstanding	75.42	72.52	70.46	69.7	69.06	68.22
Working Capital	351.94	231.18	212.63	195.99	151.62	301.4
Book Value Per Share	7.10	6.05	6.23	5.68	2.68	4.57
Tangible Book Value	519.88	422.19	421.59	377.9	165.79	311.94
Tangible Book Value Per Share	6.89	5.82	5.98	5.42	2.40	4.57
Machinery	4.59	4.77	4.58	4.59	4.65	5.01
Construction In Progress	0.96	0.16	0.01	-	0.17	0.1
Leasehold Improvements	3.92	3.93	3.93	3.93	3.93	3.67

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q